The CLARITY trial: Adding clopidogrel to STEMI management [Classics Series]
Image: PD 1. The early addition of clopidogrel significantly reduced the incidence of infarct-related arterial re-occlusion within 30 days following ...
Image: PD 1. The early addition of clopidogrel significantly reduced the incidence of infarct-related arterial re-occlusion within 30 days following ...
Image: PD 1. Bivalirudin, initiated during transport for primary PCI in patients with STEMI, improved 30-day clinical outcomes with a ...
Image: PD In this section, we will highlight the key high-impact studies, updates, and analyses published in medicine during the ...
Image: PD 1. Among patients diagnosed with non ST-segment elevation myocardial infarction (NSTEMI) independent of cardiac troponin levels, 26% of ...
Image: CC/JHeauser 1. For early STEMI patients who could not undergo timely PCI within 1 hour, prehospital fibrinolysis coupled with ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.